Abstract |
Fifteen patients with severe or very severe inflammatory bowel disease on corticosteroids but not responding to medication received 12 sessions of "gut-focused hypnotherapy" and were followed up for a mean duration of 5.4 years with disease severity being graded as remission, mild, moderate, severe, or very severe. Two patients (13.4%) failed to respond and required surgery. At follow-up for the remaining 13 patients, 4 (26.6%) were in complete remission, 8 (53.3%) had mild severity, and 1 (6.7%) was moderately severe. Quality of life became good or excellent in 12 (79.9%). Corticosteroid requirements dramatically declined with 60% of patients stopping them completely and not requiring any during follow-up. Hypnotherapy appears to be a promising adjunctive treatment for inflammatory bowel disease and has steroid sparing effects. Controlled trials to clearly define its role in this disease area are justified.
|
Authors | Vivien Miller, Peter J Whorwell |
Journal | The International journal of clinical and experimental hypnosis
(Int J Clin Exp Hypn)
Vol. 56
Issue 3
Pg. 306-17
(Jul 2008)
ISSN: 1744-5183 [Electronic] England |
PMID | 18569141
(Publication Type: Journal Article)
|
Chemical References |
- Adrenal Cortex Hormones
- Anti-Inflammatory Agents, Non-Steroidal
- Immunosuppressive Agents
- Mesalamine
- Azathioprine
|
Topics |
- Adolescent
- Adrenal Cortex Hormones
(therapeutic use)
- Adult
- Anti-Inflammatory Agents, Non-Steroidal
(therapeutic use)
- Azathioprine
(therapeutic use)
- Colitis, Ulcerative
(psychology, therapy)
- Combined Modality Therapy
- Crohn Disease
(psychology, therapy)
- Female
- Humans
- Hypnosis
- Immunosuppressive Agents
(therapeutic use)
- Male
- Mesalamine
(therapeutic use)
- Middle Aged
- Quality of Life
(psychology)
- Secondary Prevention
- Suggestion
- Young Adult
|